279 related articles for article (PubMed ID: 8979089)
1. TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers.
Geltinger C; Hörtnagel K; Polack A
Gene Expr; 1996; 6(2):113-27. PubMed ID: 8979089
[TBL] [Abstract][Full Text] [Related]
2. Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.
Wittekindt NE; Hörtnagel K; Geltinger C; Polack A
Nucleic Acids Res; 2000 Feb; 28(3):800-8. PubMed ID: 10637333
[TBL] [Abstract][Full Text] [Related]
3. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.
Polack A; Feederle R; Klobeck G; Hörtnagel K
EMBO J; 1993 Oct; 12(10):3913-20. PubMed ID: 8404859
[TBL] [Abstract][Full Text] [Related]
4. The role of immunoglobulin kappa elements in c-myc activation.
Hörtnagel K; Mautner J; Strobl LJ; Wolf DA; Christoph B; Geltinger C; Polack A
Oncogene; 1995 Apr; 10(7):1393-401. PubMed ID: 7731690
[TBL] [Abstract][Full Text] [Related]
5. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
6. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
7. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
Gerbitz A; Mautner J; Geltinger C; Hörtnagel K; Christoph B; Asenbauer H; Klobeck G; Polack A; Bornkamm GW
Oncogene; 1999 Mar; 18(9):1745-53. PubMed ID: 10208435
[TBL] [Abstract][Full Text] [Related]
9. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3' to the TATA box.
Sjøttem E; Anderssen S; Johansen T
J Virol; 1996 Jan; 70(1):188-98. PubMed ID: 8523525
[TBL] [Abstract][Full Text] [Related]
10. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
Hu HM; Kanda K; Zhang L; Boxer LM
Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
[TBL] [Abstract][Full Text] [Related]
11. c-Myc and Sp1/3 are required for transactivation of hamster telomerase catalytic subunit gene promoter.
Park NH; Guo W; Kim HR; Kang MK; Park NH
Int J Oncol; 2001 Oct; 19(4):755-61. PubMed ID: 11562751
[TBL] [Abstract][Full Text] [Related]
12. Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat.
Boisclair YR; Brown AL; Casola S; Rechler MM
J Biol Chem; 1993 Nov; 268(33):24892-901. PubMed ID: 7693708
[TBL] [Abstract][Full Text] [Related]
13. Specificity proteins Sp1 and Sp3 interact with the rat GTP cyclohydrolase I proximal promoter to regulate transcription.
Chandran NS; Vunnava P; Wu Y; Kapatos G
J Neurochem; 2008 Mar; 104(5):1233-48. PubMed ID: 18004997
[TBL] [Abstract][Full Text] [Related]
14. A Myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma.
Hu HM; Arcinas M; Boxer LM
J Biol Chem; 2002 Mar; 277(12):9819-24. PubMed ID: 11777933
[TBL] [Abstract][Full Text] [Related]
15. Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation.
Krumm A; Hickey LB; Groudine M
Genes Dev; 1995 Mar; 9(5):559-72. PubMed ID: 7698646
[TBL] [Abstract][Full Text] [Related]
16. Activation functions of transcription factor Sp1 at U2 snRNA and TATA box promoters.
Forsberg M; Ström AC; Lillhager P; Westin G
Biol Chem Hoppe Seyler; 1995 Nov; 376(11):661-9. PubMed ID: 8962675
[TBL] [Abstract][Full Text] [Related]
17. FOXM1c and Sp1 transactivate the P1 and P2 promoters of human c-myc synergistically.
Wierstra I; Alves J
Biochem Biophys Res Commun; 2007 Jan; 352(1):61-8. PubMed ID: 17141659
[TBL] [Abstract][Full Text] [Related]
18. Molecular and functional characterization of the promoter region of the mouse LDH/C gene: enhancer-assisted, Sp1-mediated transcriptional activation.
Yang J; Thomas K
Nucleic Acids Res; 1997 Jun; 25(11):2213-20. PubMed ID: 9153323
[TBL] [Abstract][Full Text] [Related]
19. Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site.
Pelletier MR; Hatada EN; Scholz G; Scheidereit C
Nucleic Acids Res; 1997 Oct; 25(20):3995-4003. PubMed ID: 9321649
[TBL] [Abstract][Full Text] [Related]
20. Sp1 is essential for both enhancer-mediated and basal activation of the TATA-less human adenosine deaminase promoter.
Dusing MR; Wiginton DA
Nucleic Acids Res; 1994 Feb; 22(4):669-77. PubMed ID: 8127716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
